Multi-disciplinary Care for Brain Metastases

Last updated: January 27, 2026
Sponsor: University of Vermont Medical Center
Overall Status: Active - Recruiting

Phase

N/A

Condition

Neoplasm Metastasis

Treatment

health services intervention

Clinical Study ID

NCT06280300
UVMMC2203
  • Ages > 18
  • All Genders

Study Summary

This is a health services intervention study aimed at understanding the impact of intensive multi-disciplinary care compared with standard care on patient-reported symptom outcomes and prognostic awareness in patients with brain metastases.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients of all genders must be at least 18 years of age.

  • Patients must have histologically confirmed, newly diagnosed brain metastases fromknown or suspected solid tumor primary neoplasms.

  • Patients must be able to accurately provide self-report data (e.g. per clinicaljudgment, cognitive function is intact).

  • Patients must be able to complete questionnaires in English.

  • Patients must have the ability to provide informed consent.

Exclusion

Exclusion Criteria:

  • Patients who are < 18 years of age are not eligible.

  • Patients who are Pregnant are not eligible.

Study Design

Total Participants: 40
Treatment Group(s): 1
Primary Treatment: health services intervention
Phase:
Study Start date:
November 16, 2023
Estimated Completion Date:
July 01, 2027

Study Description

This is a cohort study of patient with newly diagnosed brain metastases assigned to standard of care (SOC) or intensive multi-disciplinary care (IMDC). Care for all patients with brain metastases involves complex medical decision making and requires input for multiple stakeholders, including medical oncology, neurosurgery, radiation oncology, and neuro-oncology. Palliative care should be an essential component of the care team for all patients with brain metastases by the very nature of this advanced malignancy. At the University of Vermont, our current process for diagnosis and management of patients with brain metastases relies heavily on the physician and team who make the initial diagnosis to consult others as they see appropriate. This process may look different for different patients. We rationalize that a systematic approach with intensive multidisciplinary care (IMDC) will benefit patients with brain metastases by providing consistent access to multi-disciplinary discussion.

Connect with a study center

  • University of Vermont Medical Center

    Burlington, Vermont 05401
    United States

    Site Not Available

  • University of Vermont Medical Center

    Burlington 5234372, Vermont 5242283 05401
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.